A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan

Ming Chyi Huang, Chun Hsin Chen, Jeng Ming Yu, Chiao Chicy Chen

研究成果: 雜誌貢獻文章

16 引文 (Scopus)

摘要

The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45% (n = 9/20) of the naltrexone-treated subjects and 35% (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.

原文英語
頁(從 - 到)289-292
頁數4
期刊Addiction Biology
10
發行號3
DOIs
出版狀態已發佈 - 九月 2005

指紋

Naltrexone
Taiwan
Alcoholism
Placebos
Alcohols
Therapeutics
Alcoholics
Psychotherapy
Recurrence

ASJC Scopus subject areas

  • Medicine (miscellaneous)

引用此文

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. / Huang, Ming Chyi; Chen, Chun Hsin; Yu, Jeng Ming; Chen, Chiao Chicy.

於: Addiction Biology, 卷 10, 編號 3, 09.2005, p. 289-292.

研究成果: 雜誌貢獻文章

Huang, Ming Chyi ; Chen, Chun Hsin ; Yu, Jeng Ming ; Chen, Chiao Chicy. / A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. 於: Addiction Biology. 2005 ; 卷 10, 編號 3. 頁 289-292.
@article{03e1ee506d924642b6bf114162cfa0ee,
title = "A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan",
abstract = "The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45{\%} (n = 9/20) of the naltrexone-treated subjects and 35{\%} (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.",
author = "Huang, {Ming Chyi} and Chen, {Chun Hsin} and Yu, {Jeng Ming} and Chen, {Chiao Chicy}",
year = "2005",
month = "9",
doi = "10.1080/13556210500223504",
language = "English",
volume = "10",
pages = "289--292",
journal = "Addiction Biology",
issn = "1355-6215",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan

AU - Huang, Ming Chyi

AU - Chen, Chun Hsin

AU - Yu, Jeng Ming

AU - Chen, Chiao Chicy

PY - 2005/9

Y1 - 2005/9

N2 - The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45% (n = 9/20) of the naltrexone-treated subjects and 35% (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.

AB - The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45% (n = 9/20) of the naltrexone-treated subjects and 35% (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.

UR - http://www.scopus.com/inward/record.url?scp=24944492107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944492107&partnerID=8YFLogxK

U2 - 10.1080/13556210500223504

DO - 10.1080/13556210500223504

M3 - Article

C2 - 16109592

AN - SCOPUS:24944492107

VL - 10

SP - 289

EP - 292

JO - Addiction Biology

JF - Addiction Biology

SN - 1355-6215

IS - 3

ER -